82491-025-10 : NDC 2026 Code

82491-025-10 : Bevacizumab-vikg ( Lytenava )

Additionally :

You can get information about “82491-025-10” NDC code in 82491-025-10 in HTML format

HTML | 82491-025-10 in TXT (Plain Text) format

TXT | 82491-025-10 in PDF (Portable Document Format)

PDF | 82491-025-10 in JSON format

JSON formats.

NDC Code : 82491-025-10 – XML Data Format

                    
<?xml version="1.0" encoding="UTF-8"?>
<NDC>
	<NDCCode>
		82491-025-10
	</NDCCode>
	<PackageDescription>
		1 VIAL, GLASS in 1 CARTON (82491-025-10)  / 1 INJECTION in 1 VIAL, GLASS
	</PackageDescription>
	<NDC11Code>
		82491-0025-10
	</NDC11Code>
	<ProductNDC>
		82491-025
	</ProductNDC>
	<ProductTypeName>
		HUMAN PRESCRIPTION DRUG
	</ProductTypeName>
	<ProprietaryName>
		Lytenava
	</ProprietaryName>
	<ProprietaryNameSuffix/>
	<NonProprietaryName>
		Bevacizumab-vikg
	</NonProprietaryName>
	<DosageFormName>
		INJECTION
	</DosageFormName>
	<RouteName>
		INTRAVITREAL
	</RouteName>
	<StartMarketingDate>
		20260716
	</StartMarketingDate>
	<EndMarketingDate/>
	<MarketingCategoryName>
		BLA
	</MarketingCategoryName>
	<ApplicationNumber>
		BLA761320
	</ApplicationNumber>
	<LabelerName>
		Outlook Therapeutics, Inc.
	</LabelerName>
	<SubstanceName>
		BEVACIZUMAB
	</SubstanceName>
	<StrengthNumber>
		1.25
	</StrengthNumber>
	<StrengthUnit>
		mg/1
	</StrengthUnit>
	<Pharm_Classes>
		Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
	</Pharm_Classes>
	<DEASchedule/>
	<Status>
		Active
	</Status>
	<LastUpdate>
		2026-08-07
	</LastUpdate>
	<PackageNdcExcludeFlag>
		N
	</PackageNdcExcludeFlag>
	<ProductNdcExcludeFlag>
		N
	</ProductNdcExcludeFlag>
	<ListingRecordCertifiedThrough>
		20271231
	</ListingRecordCertifiedThrough>
	<StartMarketingDatePackage>
		20260716
	</StartMarketingDatePackage>
	<EndMarketingDatePackage/>
	<SamplePackage>
		N
	</SamplePackage>
</NDC>

NDC XML XSD Schema

                    
<xs:schema attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema">
  <xs:element name="NDC">
    <xs:complexType>
      <xs:sequence>
        <xs:element type="xs:string" name="NDCCode"/>
        <xs:element type="xs:string" name="PackageDescription"/>
        <xs:element type="xs:string" name="NDC11Code"/>
        <xs:element type="xs:string" name="ProductNDC"/>
        <xs:element type="xs:string" name="ProductTypeName"/>
        <xs:element type="xs:string" name="ProprietaryName"/>
        <xs:element type="xs:string" name="ProprietaryNameSuffix"/>
        <xs:element type="xs:string" name="NonProprietaryName"/>
        <xs:element type="xs:string" name="DosageFormName"/>
        <xs:element type="xs:string" name="RouteName"/>
        <xs:element type="xs:string" name="StartMarketingDate"/>
        <xs:element type="xs:string" name="EndMarketingDate"/>
        <xs:element type="xs:string" name="MarketingCategoryName"/>
        <xs:element type="xs:string" name="ApplicationNumber"/>
        <xs:element type="xs:string" name="LabelerName"/>
        <xs:element type="xs:string" name="SubstanceName"/>
        <xs:element type="xs:string" name="StrengthNumber"/>
        <xs:element type="xs:string" name="StrengthUnit"/>
        <xs:element type="xs:string" name="Pharm_Classes"/>
        <xs:element type="xs:string" name="DEASchedule"/>
        <xs:element type="xs:string" name="Status"/>
        <xs:element type="xs:string" name="LastUpdate"/>
        <xs:element type="xs:string" name="PackageNdcExcludeFlag"/>
        <xs:element type="xs:string" name="ProductNdcExcludeFlag"/>
        <xs:element type="xs:string" name="ListingRecordCertifiedThrough"/>
        <xs:element type="xs:string" name="StartMarketingDatePackage"/>
        <xs:element type="xs:string" name="EndMarketingDatePackage"/>
        <xs:element type="xs:string" name="SamplePackage"/>
      </xs:sequence>
    </xs:complexType>
  </xs:element>
</xs:schema>